Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program

被引：0

作者：

Xin Du

Jie Jin

Zhen Cai

Fangping Chen

Dao-bin Zhou

Li Yu

Xiaoyan Ke

Xiao Li

Depei Wu

Fanyi Meng

Dena DeMarco

Jingshan Zhang

Jay Mei

Jian Hou

机构：

[1] Guangdong General Hospital,The 1st Affiliated Hospital

[2] Zhejiang University,Department of Hematology

[3] Xiangya Hospital of Central South University,undefined

[4] Peking Union Medical College Hospital,undefined

[5] The 301 Hospital-Chinese PLA General Hospital,undefined

[6] Peking University Third Hospital,undefined

[7] Shanghai 6th Hospital,undefined

[8] The 1st Affiliated Hospital of Soochow University,undefined

[9] Nanfang Hospital of Southern Medicine University in Guangzhou,undefined

[10] Celgene Corporation,undefined

[11] Shanghai Changzheng Hospital,undefined

来源：

BMC Cancer | / 16卷

关键词：

Relapsed/refractory multiple myeloma; Chinese patients; Lenalidomide; Low-dose dexamethasone; Dexamethasone;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] A Phase 1 and 2 Study of Filanesib Alone and in Combination With Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma [J].

Shah, Jatin J. ;

Kaufman, Jonathan L. ;

Zonder, Jeffrey A. ;

Cohen, Adam D. ;

Bensinger, William I. ;

Hilder, Brandi W. ;

Rush, Selena A. ;

Walker, Duncan H. ;

Tunquist, Brian J. ;

Litwiler, Kevin S. ;

Ptaszynski, Mieke ;

Orlowski, Robert Z. ;

Lonial, Sagar .

CANCER, 2017, 123 (23) :4617-4630

[42] Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment [J].

Lee, Sung-Eun ;

Lim, Ji-Young ;

Ryu, Da-Bin ;

Kim, Tae Woo ;

Park, Sung Soo ;

Jeon, Young-Woo ;

Yoon, Jae-Ho ;

Cho, Byung-Sik ;

Eom, Ki-Seong ;

Kim, Yoo-Jin ;

Kim, Hee-Je ;

Lee, Seok ;

Cho, Seok-Goo ;

Kim, Dong-Wook ;

Lee, Jong Wook ;

Min, Chang-Ki .

ANNALS OF HEMATOLOGY, 2018, 97 (11) :2163-2171

[43] Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment [J].

Sung-Eun Lee ;

Ji-Young Lim ;

Da-Bin Ryu ;

Tae Woo Kim ;

Sung Soo Park ;

Young-Woo Jeon ;

Jae-Ho Yoon ;

Byung-Sik Cho ;

Ki-Seong Eom ;

Yoo-Jin Kim ;

Hee-Je Kim ;

Seok Lee ;

Seok-Goo Cho ;

Dong-Wook Kim ;

Jong Wook Lee ;

Chang-Ki Min .

Annals of Hematology, 2018, 97 :2163-2171

[44] Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study [J].

Kropff, Martin ;

Vogel, Martin ;

Bisping, Guido ;

Schlag, Rudolf ;

Weide, Rudolf ;

Knauf, Wolfgang ;

Fiechtner, Heinrich ;

Kojouharoff, Georgi ;

Kremers, Stephan ;

Berdel, Wolfgang E. .

ANNALS OF HEMATOLOGY, 2017, 96 (11) :1857-1866

[45] Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial [J].

Dimopoulos, Meletios ;

Weisel, Katja ;

van de Donk, Niels W. C. J. ;

Ramasamy, Karthik ;

Gamberi, Barbara ;

Streetly, Matthew ;

Offidani, Massimo ;

Bridoux, Frank ;

de la Rubia, Javier ;

Mateos, Maria-Victoria ;

Ardizzoia, Antonio ;

Kueenburg, Elisabeth ;

Collins, Shona ;

Di Micco, Antonia ;

Rosettani, Barbara ;

Li, Yan ;

Bacon, Pamela ;

Sonneveld, Pieter .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (20) :2035-+

[46] Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial [J].

San Miguel, Jesus ;

Weisel, Katja ;

Moreau, Philippe ;

Lacy, Martha ;

Song, Kevin ;

Delforge, Michel ;

Karlin, Lionel ;

Goldschmidt, Hartmut ;

Banos, Anne ;

Oriol, Albert ;

Alegre, Adrian ;

Chen, Christine ;

Cavo, Michele ;

Garderet, Laurent ;

Ivanova, Valentina ;

Martinez-Lopez, Joaquin ;

Belch, Andrew ;

Palumbo, Antonio ;

Schey, Stephen ;

Sonneveld, Pieter ;

Yu, Xin ;

Sternas, Lars ;

Jacques, Christian ;

Zaki, Mohamed ;

Dimopoulos, Meletios .

LANCET ONCOLOGY, 2013, 14 (11) :1055-1066

[47] Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma [J].

Azarm, Taleb ;

Akbari, Mojtaba ;

Azarm, Arezo ;

Mohager, Hamid .

JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (01) :8-14

[48] Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma [J].

Kumar, Shaji K. ;

Grzasko, Norbert ;

Delimpasi, Sosana ;

Jedrzejczak, Wieslaw W. ;

Grosicki, Sebastian ;

Kyrtsonis, Marie-Christine ;

Spencer, Andrew ;

Gupta, Neeraj ;

Teng, Zhaoyang ;

Byrne, Catriona ;

Labotka, Richard ;

Dimopoulos, Meletios A. .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) :536-546

Weisel, Katja ;

Dimopoulos, Meletios ;

Moreau, Philippe ;

Yagci, Munci ;

Larocca, Alessandra ;

Kanate, Abraham S. ;

Vural, Filiz ;

Cascavilla, Nicola ;

Basu, Supratik ;

Johnson, Peter ;

Byeff, Peter ;

Hus, Marek ;

Rodriguez-Otero, Paula ;

Muelduer, Ercan ;

Anttila, Pekka ;

Hayden, Patrick J. ;

Krauth, Maria-Theresa ;

Lucio, Paulo ;

Ben-Yehuda, Dina ;

Mendeleeva, Larisa ;

Guo, Shien ;

Yu, Xin ;

Grote, Lara ;

Biyukov, Tsvetan ;

Dhanasiri, Sujith ;

Richardson, Paul .

LEUKEMIA & LYMPHOMA, 2020, 61 (08) :1850-1859

[50] Dose-adjusted Lenalidomide Combined with Low-dose Dexamethasone Rescues Older Patients with Bortezomib-resistant Multiple Myeloma [J].

Yamasaki, Satoshi ;

Kohno, Kentaro ;

Kadowaki, Masanori ;

Takase, Ken ;

Okamura, Seiichi .

INTERNAL MEDICINE, 2015, 54 (14) :1711-1715

← 1 2 3 4 5 →